BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 37870696)

  • 1. Novel Therapeutic Options for Small Cell Lung Cancer.
    Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
    Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
    Gadgeel SM
    Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highlights of PAPR Inhibitors in Small Cell Lung Cancer].
    Zhang S; Liu J; Yang C; Zhang L; Li S; Bao H; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):806-810. PubMed ID: 32752582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
    Xiong J; Barayan R; Louie AV; Lok BH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):521-542. PubMed ID: 35917883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCLC-State of the Art and What Does the Future Have in Store?
    Kahnert K; Kauffmann-Guerrero D; Huber RM
    Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the treatment of small cell lung cancer.
    Hiddinga BI; Raskin J; Janssens A; Pauwels P; Van Meerbeeck JP
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34261744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of small cell lung cancer: recent advances.
    Chu X; Han C; Su C
    Curr Opin Oncol; 2022 Jan; 34(1):83-88. PubMed ID: 34698669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the biology of SCLC: implications for therapy.
    Sabari JK; Lok BH; Laird JH; Poirier JT; Rudin CM
    Nat Rev Clin Oncol; 2017 Sep; 14(9):549-561. PubMed ID: 28534531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
    Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
    Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
    Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
    Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies.
    McNamee N; da Silva IP; Nagrial A; Gao B
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive-stage small-cell lung cancer: Current management and future directions.
    Yu Y; Chen K; Fan Y
    Int J Cancer; 2023 Jun; 152(11):2243-2256. PubMed ID: 36346100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and discussion of the treatment guidelines for small cell lung cancer.
    Zhao H; Ren D; Liu H; Chen J
    Thorac Cancer; 2018 Jul; 9(7):769-774. PubMed ID: 29770597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DNA damage in SCLC.
    Foy V; Schenk MW; Baker K; Gomes F; Lallo A; Frese KK; Forster M; Dive C; Blackhall F
    Lung Cancer; 2017 Dec; 114():12-22. PubMed ID: 29173760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
    Horn L; Reck M; Spigel DR
    Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell Lung Cancer (SCLC).
    Grenda A; Krawczyk P; Obara A; Gajek Ł; Łomża-Łaba A; Milanowski J
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal pathways and precision therapy of small-cell lung cancer.
    Yuan M; Zhao Y; Arkenau HT; Lao T; Chu L; Xu Q
    Signal Transduct Target Ther; 2022 Jun; 7(1):187. PubMed ID: 35705538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New Advances in the Treatment for Small Cell Lung Cancer].
    Cui X; Song P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):355-362. PubMed ID: 31196369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Zhang Z; Zhang C; Luo Y; Wu P; Zhang G; Zeng Q; Wang L; Yang Z; Xue L; Zheng B; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
    BMC Med; 2021 Nov; 19(1):284. PubMed ID: 34802443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.